Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

INDUSTRY 22OTHER 17UNKNOWN 2NETWORK 1

Study Type

Observational 2

Sponsor

Cancer Type

Breast 2

Conditions

Hormone Receptor Positive Advanced Breast Cancer 1Breast Neoplasms 1

Interventions

palbociclib 2Fulvestrant 2pembrolizumab 1niraparib 1exemestane 1Therapeutics 1Standard of Care 1Radiotherapy, Adjuvant 1Radiation 1Pharmaceutical Preparations 1Neoadjuvant Therapy 1Methods 1Letrozole 1Immunotherapy 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Observational × palbociclib × Clear all
NCT05000736 2022-04-29

CAPACITY

ChineseAMS

Unknown
600 enrolled
Breast

Hormone Receptor Positive Advanced Breast Cancer

NCT04289974 2020-02-28

Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer

ChineseAMS

Unknown
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡